Aerie Pharmaceuticals is a pharmaceutical company dedicated to developing treatments for glaucoma and other eye conditions. Founded in 2005. Revenue $ 83 million (2020). Capitalization $ 489 million Medium-term trade following a trend. The low of the candlestick at $ 9.68 formed a support level upon a repeated approach to the base of the trend reversal. The...
AERI is a bullish stock on the Daily. 200 is gently sloping up, and the 50 and 20 have made comfortable distance. RSI divergence has occurred, and a cross on the stochastic seems imminent. I was filled at the demand zone, but the bullish engulfing candle suggests this pullback may be finished. Play at your own risk, or, put this order in on a simulator. For...
BUY AERI - AERIE PHARMACEUTICALS IN - STRONG BUY ON WEEKLY CHART
we will see how this plays out over the next few days. its likely this will go down before rally.
Detected bullish divergence with bullish MACD signal line cross. Needs to break and confirm MA resistances. feedback welcome
AERI has had a bad year. From $50 down to under $18. However price is slowing down from its descent and recently formed a double bottom. And while price has been decreasing and stabilizing, RSI is moving up. Same for Accum/Dist, looks like moving out of the selling phase and into buying. So may be opportunity for a bounce here. It's already at the double bottom,...
Looking for follow-thru on Cup/Handle, possibly to 60.
Aerie Pharmaceuticals is both over bought and is fundamentally not a very good company for these reasons I suggest shorting AERI. NASDAQ:AERI
Contracting vol. NR7 NR3 5ema is still a bit far away; preferred to be touching today's low Inside bar
Great premium income opportunity here! Details are on chart.
I almost ran out of colors, lolz. Looking pretty good for higher to my eyes.
Another Ending Diagonal example from the Pharma industry. These overnight reversals are a beast. I see no signs Aerie is setting up a long. Correction may not be over. Just picked it as a historical ED example.
Becareful with low volume stocks and specially companies that expect FDA approval for any products that are in trial process. This stock formed a bullish pattern that in a rare cases is reliable as well as the bullish harami that was confirmed for Friday's price action. If you decide to take a long position use a tight stop loss at recent swing low at and around...